2012
SJR Q4
JCR Q4 · 0,3
2 matched articles
Journal detail
Research Communications in Molecular Pathology and Pharmacology
- Publisher
- PJD Publications Ltd
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
10780297
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,107
- Quartile Q4
- H-Index 40
- Cites/doc 0
- Docs (3y) 6
- Cites (3y) 1
Clarivate
Web of Science · JCR · 2002
- JCR Q Q4
- JIF 0,3
- 5Y JIF —
- JCI —
Subject classification
Categories (SJR)
- Medicine (miscellaneous) Q4
- Molecular Medicine Q4
- Pharmacology Q4
Areas
- Biochemistry, Genetics and Molecular Biology
- Medicine
- Pharmacology, Toxicology and Pharmaceutics
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2012 | Q4 | — | 0,107 | — | — | — | — | 40 |
| 2011 | Q4 | — | 0,103 | — | — | — | — | 40 |
| 2010 | Q4 | — | 0,101 | — | — | — | — | 40 |
| 2002 | — | Q4 | — | 0,3 | — | — | — | — |
| 2001 | — | Q4 | — | 0,4 | — | — | — | — |
| 2000 | — | Q4 | — | 0,5 | — | — | — | — |
| 1999 | — | Q3 | — | 0,7 | — | — | — | — |
| 1998 | — | Q3 | — | 0,6 | — | — | — | — |
| 1997 | — | Q4 | — | 0,4 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2002 | PATHOLOGY | SCIE | Q4 | — | 62/64 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 177/188 |
| 2001 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 286/308 |
| 2001 | PATHOLOGY | SCIE | Q4 | — | 60/66 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 171/186 |
| 2000 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 275/310 |
| 2000 | PATHOLOGY | SCIE | Q4 | — | 56/67 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 160/181 |
| 1999 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 244/295 |
| 1999 | PATHOLOGY | SCIE | Q3 | — | 49/66 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 123/175 |
| 1998 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 253/295 |
| 1998 | PATHOLOGY | SCIE | Q4 | — | 52/68 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 126/178 |
| 1997 | BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q4 | — | 237/253 |
| 1997 | PATHOLOGY | SCIE | Q4 | — | 56/66 |
| 1997 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 142/157 |